Leap Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Leap Therapeutics Stock Forecast and Price Target
The average target price set lately by three experts for Leap Therapeutics to reach by the end of the year is $12.00, which would imply a potential upside of approximately 278.55 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of $16.00 and a low estimate of $7.00.
278.55% Upside
Leap Therapeutics Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Leap Therapeutics's Price has grown, increasing from $0.00 to $0.00 – an increase of 100.00%. For next year, the 5 analysts predict Fair Value of $3.40, which would mean an increase of 100.00%. Over the next seven years, the pros' prediction is Fair Valueof $6.43, which would mean a seven-year growth forecast of 100.00%.
Leap Therapeutics Revenue Forecast for 2023 - 2025 - 2030
Leap Therapeutics's Revenue has decreased by 0.00% In the last year, from $1.50M to $1.50M. In the following year, the 5 analysts surveyed believe that Leap Therapeutics's Revenue will decrease by 80.00%, reaching $300.00k. Over the next seven years, the pros' prediction is Revenueof $316.20M, which would mean a seven-year growth forecast of 20980.00%.
.jpg)
Leap Therapeutics EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Leap Therapeutics's EBITDA has grown by 93.49%, from $-28.27M to $-54.70M. For the next year, 0 analysts project Leap Therapeutics's EBITDA to drop by 27.58%, reaching $-39.61M. By 2030, professionals believe that Leap Therapeutics's EBITDA will decrease by 23.40%, reaching $-41.90M – a concerning trend for the company.
Leap Therapeutics EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Leap Therapeutics's EBIT has grown from $-28.31M to $-54.71M – a 93.25% increase. Next year, analysts are expecting EBIT to reach $-72.85M – an increase of 33.16%. By 2030, professionals believe that Leap Therapeutics's EBIT will decrease by 289.09%, reaching $103.45M – a concerning trend for the company.
Leap Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Leap Therapeutics's EPS has grown, increasing from $-6.30 to $0.00 – an increase of 100.00%. For next year, the 5 analysts predict EPS of $-2.15, which would mean an increase of 100.00%. Over the next seven years, the pros' prediction is EPSof $1.09, which would mean a seven-year growth forecast of 100.00%.
.jpg)